Carrageenan vs High-Fructose Corn Syrup: which is worse?
Quick answer: Carrageenan carries the heavier risk profile. Carrageenan is — in the EU and — in the US; High-Fructose Corn Syrup is — in the EU and — in the US.
| Property | Carrageenan | High-Fructose Corn Syrup |
|---|---|---|
| EU status | — | — |
| US status | — | — |
| Risk level | — | — |
| Banned in | European Union (banned in infant formula specifically since 2018) | — |
| Restricted in | European Union (restricted in some applications; ongoing EFSA re-evaluation), United States (removed from USDA Organic certification for processed products in 2018) | European Union (historically limited by isoglucose quota system making it economically noncompetitive; quotas removed 2017 but EU sugar industry remains dominant) |
| Category | additive | additive |
| Where it hides | — | — |
What is Carrageenan?
Carrageenan is a polysaccharide extracted from red seaweed (primarily Chondrus crispus and Eucheuma species). Used as a thickener, gelling agent, and stabilizer in food and personal care products. Food-grade carrageenan (undegraded) is different from degraded carrageenan (poligeenan), which is not food-grade and is a known inflammatory agent.
What is High-Fructose Corn Syrup?
High-fructose corn syrup (HFCS) is a liquid sweetener produced by enzymatically converting a portion of corn syrup's glucose to fructose. The most common forms are HFCS-55 (55% fructose, 45% glucose, used primarily in beverages) and HFCS-42 (42% fructose, used in processed foods). It became dominant in the US food supply in the 1970s-1980s.
Documented risks
Carrageenan: Carrageenan safety has been disputed for decades, centering on the distinction between undegraded (food-grade, high-molecular-weight) carrageenan and degraded carrageenan (poligeenan). Poligeenan, produced by acid hydrolysis, is a known inflammatory and carcinogenic agent in animals. Food-grade carrageenan is a different molecule, but critics argue it can partially degrade in the acidic stomach environment. Dr. Joanne Tobacman at the University of Illinois has published multiple studies on carrageenan-induced inflammation. A 2001 paper in Environmental Health Perspectives (PMC1240867) demonstrated that food-grade carrageenan activates inflammatory signaling pathways (NF-κB) in human intestinal cells, inhibits insulin signaling, and causes intestinal injury in animal models. Her 2012 review in the Journal of Diabetes Research summarized multiple animal studies showing intestinal inflammation, ulcerations, and neoplasms. A 2017 review in Environmental Health Perspectives (Bhide et al.) found carrageenan activated NF-κB inflammatory pathways and could potentially exacerbate inflammatory bowel disease (IBD) in susceptible individuals. Major regulatory bodies including EFSA (comprehensive 2018 re-evaluation) and the WHO/FAO JECFA have consistently concluded that undegraded food-grade carrageenan does not cause cancer or significant harm at typical food use levels in healthy adults. However, the EU precautionary ban in infant formula (2018) acknowledged that infants' developing digestive systems may be more vulnerable to carrageenan's potential effects, and insufficient evidence of safety existed for this specific high-risk population. The USDA's removal of carrageenan from Organic certification (2018) reflected organic industry stakeholder concern despite the continued regulatory permission. Individuals with IBD or gut sensitivity may have reason to avoid carrageenan based on in vitro and animal data, even if the general population safety at food use levels is defended by EFSA and JECFA.
High-Fructose Corn Syrup: HFCS has been at the center of one of nutrition science's most contentious debates for 30+ years. The core concern is that fructose is metabolized differently than glucose: fructose is processed primarily in the liver where it can be converted to fat (de novo lipogenesis), contributing to non-alcoholic fatty liver disease (NAFLD) and elevated triglycerides. A landmark 2004 paper by Bray, Nielsen, and Popkin in the American Journal of Clinical Nutrition proposed that the increase in HFCS consumption from the 1970s tracked with rising obesity rates. This hypothesis was widely publicized but contested; subsequent controlled research found that HFCS and sucrose produce similar metabolic effects calorie-for-calorie. However, the broader research on fructose metabolism supports metabolic concerns. A 2012 PLOS ONE study (Basu et al.) found higher sugar-sweetened beverage consumption associated with increased rates of metabolic syndrome and type 2 diabetes. A 2012 Nature commentary by Lustig, Schmidt, and Brindis ('The Toxic Truth About Sugar') argued fructose's hepatic metabolism makes it uniquely harmful — prompting significant scientific debate. Key established effects of high fructose intake include: increased visceral fat, elevated blood triglycerides, increased uric acid (gout risk), worsened insulin resistance, and accelerated NAFLD progression. These effects occur with high fructose intake from any source (HFCS or sucrose), making HFCS no inherently worse than sucrose at equivalent doses — but its ubiquity in US processed foods contributes to chronically elevated fructose exposure at a population level. Mercury contamination: in 2009, independent testing by the Institute for Agriculture and Trade Policy (IATP) and a study in Environmental Health found mercury traces in some HFCS samples from certain manufacturers using mercury-grade caustic soda. The industry has largely transitioned to mercury-free processing since these findings.
Scan a barcode and we'll flag both Carrageenan and High-Fructose Corn Syrup (plus 200+ other ingredients banned overseas).
Scan free →